Description
Cinnarizine Tablets (25 mg / 75 mg)
Healthy Inc is a premier global supplier of high-precision vestibular and circulatory therapies. We provide premium Cinnarizine Tablets, manufactured in WHO–GMP certified specialized solid dosage units. As a frontline treatment for vertigo and motion sickness, this product is a vital export for ENT clinics, neurology centers, and Ministry of Health (MOH) tenders in Southeast Asia, Africa, and the CIS region.
Product Overview
Cinnarizine is a piperazine derivative that functions as both a selective calcium entry blocker and an antihistamine. It is specifically engineered to stabilize the vestibular system and improve microcirculation by reducing the viscosity of the blood and inhibiting the contraction of vascular smooth muscle cells.
The “Balance & Circulation” Specialist:
- Mechanism of Action: Cinnarizine inhibits the influx of calcium ions into vestibular sensory cells and vascular smooth muscle. This suppresses the overstimulation of the labyrinth in the inner ear. Additionally, its anti-histaminic (H1) properties contribute to its potent anti-emetic effect, preventing nausea and vomiting.
- Hemorheological Effect: It improves blood flow by increasing the deformability of erythrocytes (red blood cells) and reducing high blood viscosity, making it effective for peripheral vascular disorders.
- Nocturnal Sedation: Due to its mild sedative properties, it is particularly useful for patients whose vestibular symptoms interfere with sleep or cause significant anxiety.
Technical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
| Technical Metric | Specification Standard |
|---|---|
| Active Ingredient | Cinnarizine BP / USP / IP |
| Dosage Form | Immediate Release Tablets |
| Available Strengths | 25 mg (Vestibular) / 75 mg (Cerebrovascular) |
| HS Code | 3004.90.39 (Other CNS drugs) / 2933.59.90 |
| Stability | Validated for Zone IVb (Tropical) export markets |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from ISO 9001:2015 certified units.
- Dissolution Precision: Utilizing advanced wet granulation techniques, we ensure rapid disintegration to provide quick relief from acute vertigo attacks and motion sickness.
- Impurity Control: Our quality assurance protocol ensures the absence of related piperazine impurities, maintaining the highest safety profile for chronic use in elderly patients.
- Protective Packaging: Cinnarizine is light-sensitive; our tablets are housed in high-grade Alu-Alu or Amber PVC blisters to ensure a 36-month shelf life without potency loss.
Therapeutic Indications & Clinical Symptoms
- Vestibular Disorders: Management of vertigo, tinnitus, nystagmus, nausea, and vomiting associated with Meniere’s Disease or labyrinthitis.
- Motion Sickness: Prevention of sea-sickness, air-sickness, and car-sickness.
- Peripheral Circulatory Disorders: Treatment of Raynaud’s phenomenon, intermittent claudication, and cold extremities.
- Cerebrovascular Disorders: Management of symptoms of cerebral origin such as dizziness and vascular headaches.
Dosage & Administration
- Motion Sickness: 25 mg taken 2 hours before travel, then 12.5–25 mg every 8 hours during the journey.
- Vestibular Symptoms: 25 mg three times daily.
- Peripheral Vascular Disease: 75 mg two to three times daily.
- Administration: Should be taken after meals to minimize gastrointestinal irritation.
Global Export & Contract Manufacturing Services
Healthy Inc is a verified Pharmaceutical Exporter in Mumbai, catering to ENT Specialty Centers and Retail Pharmacy Chains. We offer Third Party Manufacturing for Cinnarizine with full CTD Dossier and COPP support. Our logistics network facilitates secure transit to Vietnam, Nigeria, Uzbekistan, and the Philippines, providing WHO-GMP quality at competitive B2B prices.
Commercial Inquiries
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
